Sign in

CIK 0000310158

  • Large accelerated filer

Merck & Co., Inc.

Sign in to watch
Ticker
MRK
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
EIN
221918501
Phone
+1 908-740-4000
Business address
126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
Former names
Merck & Co. Inc., SCHERING PLOUGH CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$8,611,875
in 1 filing

Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. DeLuca Richard R. −$8.6M EVP&Pres, Merck Animal Heallth sold 34% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-11-07 FRAZIER KENNETH C Executive Chair Exercise or conversion +235,769 936,422.06
2022-11-07 FRAZIER KENNETH C Executive Chair Sale −24,914 $98.45 $2.5M 911,508.06
2022-11-07 FRAZIER KENNETH C Executive Chair Sale −126,134 $99.42 $12.5M 785,374.06
2022-11-07 FRAZIER KENNETH C Executive Chair Sale −84,721 $100.07 $8.5M 700,653.06
2022-11-07 FRAZIER KENNETH C Executive Chair Exercise or conversion · Stock Option (Right to Buy) −235,769 0
2022-11-04 FRAZIER KENNETH C Executive Chair Exercise or conversion +235,000 935,653.06
2022-11-04 FRAZIER KENNETH C Executive Chair Sale −200,190 $98.53 $19.7M 735,463.06
2022-11-04 FRAZIER KENNETH C Executive Chair Sale −34,810 $99.08 $3.4M 700,653.06
2022-11-04 FRAZIER KENNETH C Executive Chair Exercise or conversion · Stock Option (Right to Buy) −235,000 235,769
2022-11-03 FRAZIER KENNETH C Executive Chair Exercise or conversion +235,000 935,653.06
2022-11-03 FRAZIER KENNETH C Executive Chair Sale −214,617 $98.68 $21.2M 721,036.06
2022-11-03 FRAZIER KENNETH C Executive Chair Sale −20,383 $99.09 $2.0M 700,653.06
2022-11-03 FRAZIER KENNETH C Executive Chair Exercise or conversion · Stock Option (Right to Buy) −235,000 470,769
2022-11-02 FRAZIER KENNETH C Executive Chair Exercise or conversion +165,828 866,481.06
2022-11-02 FRAZIER KENNETH C Executive Chair Exercise or conversion +134,172 1,000,653.06
2022-11-02 FRAZIER KENNETH C Executive Chair Sale −205,661 $99.68 $20.5M 794,992.06
2022-11-02 FRAZIER KENNETH C Executive Chair Sale −94,339 $100.40 $9.5M 700,653.06
2022-11-02 FRAZIER KENNETH C Executive Chair Exercise or conversion · Stock Option (Right to Buy) −165,828 0
2022-11-02 FRAZIER KENNETH C Executive Chair Exercise or conversion · Stock Option (Right to Buy) −134,172 705,769
2022-11-01 FRAZIER KENNETH C Executive Chair Exercise or conversion +300,000 1,006,283.06

Page 1 of 3 · 43 trades